Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDEV.L Regulatory News (DEV)

  • There is currently no data for DEV

Director/PDMR Shareholding

25 Feb 2021 14:30

RNS Number : 3913Q
Dev Clever Holdings PLC
25 February 2021
 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Christopher Michael Jeffries

2.

Reason for the Notification

a)

Position/status

Person discharging managerial responsibilities (Director, CEO)

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dev Clever Holdings plc

b)

LEI

2138006G7ZHS9SD8XY62

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1p each

Identification Code

ISIN: GB00BH452L44

b)

Nature of the transaction

Sale of shares on exercise of call option

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.08

50,000,000

d)

Aggregated information:

· Aggregated volume

· Price

 

50,000,000 shares

£4,000,000

e)

Date of the transaction

25 February 2021

f)

Place of the Transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZELFLFLLBBBB
Date   Source Headline
19th Aug 20197:05 amRNSContract
19th Aug 20197:00 amRNSPlacing and Appointment of Joint Broker
12th Aug 20197:00 amRNSHolding(s) in Company
7th Aug 20192:30 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSVanguard: Fight for Rudiarius Update
2nd Aug 20197:00 amRNSIssue of Equity
29th Jul 20192:00 pmRNSHolding(s) in Company
26th Jul 20197:00 amRNSHalf-year Report
24th Jul 20192:05 pmRNSSecond Price Monitoring Extn
24th Jul 20192:00 pmRNSPrice Monitoring Extension
24th Jul 20197:00 amRNSContract
18th Jul 201910:40 amRNSProduct Launch
12th Jul 20194:41 pmRNSSecond Price Monitoring Extn
12th Jul 20194:35 pmRNSPrice Monitoring Extension
12th Jul 20199:05 amRNSSecond Price Monitoring Extn
12th Jul 20199:00 amRNSPrice Monitoring Extension
12th Jul 20198:00 amRNSEngage Platform: Commercial Partnership Agreement
8th Jul 20197:00 amRNSCommercial partnership agreement
5th Jul 20193:30 pmRNSPR Agency Appointment
5th Jul 201911:05 amRNSSecond Price Monitoring Extn
5th Jul 201911:00 amRNSPrice Monitoring Extension
4th Jul 20191:30 pmRNSHolding(s) in Company
28th Jun 201911:30 amRNSHolding(s) in Company
3rd Jun 20199:00 amRNSEngage update
11th Apr 20197:00 amRNSExperience: Virtual Reality Core Framework
28th Mar 20197:00 amRNSEducate:VICTAR release
22nd Mar 20197:00 amRNSEngage platform: Oracle Partner Integration
13th Mar 20197:00 amRNSCommercial partnerhip agreement
6th Mar 20197:00 amRNSEngage platform
19th Feb 20197:00 amRNSLaunchPAD Careers Platform
4th Feb 20197:00 amRNSVanguard: Fight for Rudiarius
31st Jan 20199:00 amRNSTotal Voting Rights
21st Jan 20197:00 amRNSInitial admission - Offcl Lst

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.